^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

AUR-106

i
Other names: AUR-106, AUR106, AUR 106
Associations
Company:
Dr. Reddy’s
Drug class:
PD-L1 inhibitor, TIGIT inhibitor
Related drugs:
Associations
10ms
JIVAN: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies (clinicaltrials.gov)
P1, N=30, Recruiting, Aurigene Discovery Technologies Limited | Not yet recruiting --> Recruiting
Enrollment open
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • CD4 (CD4 Molecule) • IL2 (Interleukin 2) • NCAM1 (Neural cell adhesion molecule 1)
|
AUR-106
over1year
New P1 trial • Metastases
|
AUR-106